Article

Mining of Subtype Markers for the Prognosis of Ovarian Cancer based on Methylation Data

2020-03-11

Abstract excerpt

<h4>Background: </h4> Ovarian cancer is one of three major malignancies involving the female reproductive system, and its morbidity and mortality are ranked number 3 and number 1 among gynecological tumors, respectively. DNA methylation (MET), as one of the main epigenetic modes, is closely related to the occurrence and development of ovarian cancer. To guide individualized treatment and improve the prognosis in o...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2347eaa4-b7b7-5936-9089-1d6dda16d122
DOI: 10.21203/rs.3.rs-16749/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Mining of Subtype Markers for the Prognosis of Ovarian Cancer based on Methylation DataDOI 10.21203/rs.3.rs-16749/v1Read

Mining of Subtype Markers for the Prognosis of Ovarian Cancer based on Methylation DataSemantic proximity Read

Integrating Genomic, Epigenomic, and Transcriptomic Features Reveals Modular Signatures Underlying Poor Prognosis in Ovarian CancerSemantic proximity Read

Exploration of differential methylation-driven genes to identify key epigenetic genes for prognosis of ovarian serous cystadenocarcinomaSemantic proximity Read

Gene signature of m6A-related targets to predict prognosis and immunotherapy response in ovarian cancerSemantic proximity Read

DNA Methylation Data-based Molecular Subtype Classification Related to the Prognosis of Patients with Hepatocellular CarcinomaSemantic proximity Read

Molecular Classification of Epithelial Ovarian Cancer Based on Methylation Profiling: Evidence for Survival HeterogeneitySemantic proximity Read

Molecular Subtyping of Serous Ovarian Cancer Based on Multi-omics DataSemantic proximity Read

m6A RNA methylation regulators were associated with the malignancy and prognosis of ovarian cancerSemantic proximity Read

A five-DNA methylation signature act as a novel prognostic biomarker in patients with ovarian serous cystadenocarcinomaSemantic proximity Read

Differential analysis of ovarian and endometrial cancers identifies a methylator phenotype.Semantic proximity Read

Development and validation of a DNA methylation signature to predict the progression-free survival in patients with advanced-stage ovarian cancerSemantic proximity Read

Ovarian cancer subtypes based on the regulatory genes of RNA modifications: Novel prediction model of prognosisSemantic proximity Read